A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
A study reports that the brains of a small sample of patients who died of COVID display some of the same molecular changes found in the brains of people with Alzheimer's disease.
Computer modeling of the omicron wave by Mailman's Jeffrey Shaman suggests case numbers may subside as quickly as they climbed, peaking by mid-January in New York City.
Babies born during the pandemic’s first year—even to moms who did not have COVID during pregnancy—scored slightly lower on a screening test of social and motor skills compared to pre-pandemic babies.
A new study from COVID researchers at Columbia and the University of Hong Kong adds more evidence that the omicron variant can evade the immune protection conferred by vaccines and natural infection.
Despite the emotional challenges, the holidays offer a chance to put work aside, catch our breath, and rejoice with loved ones, says Columbia psychologist Dr. Zachary Blumkin.
When should you get a COVID vaccine booster? And will it ward off new variants like omicron? Columbia physicians David Buchholz and Marcus Pereira answer often-asked questions.
Columbia immunologists have found that the infant immune system is stronger than most people think and beats the adult immune system at fighting off new pathogens.
For many patients, treatments have turned HIV/AIDS from a fatal disease into a chronic illness, but key challenges remain in realizing the goal of a world without AIDS.